US2017218380A1PendingUtilityA1
Method for directional cloning
Assignee: INNOVATIVE CELLULAR THERAPEUTICS CO LTDPriority: Oct 17, 2014Filed: Apr 7, 2017Published: Aug 3, 2017
Est. expiryOct 17, 2034(~8.2 yrs left)· nominal 20-yr term from priority
C12N 7/00C12N 15/66C12N 2740/15051C12N 15/70C12N 2740/15043C12N 15/64
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are techniques for directional cloning an insert DNA segments into a target vector. The techniques mix the target vector, the insert DNA segment, a restriction enzyme, and a DNA ligase to generate a recombinant DNA molecule.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for directional cloning, the method comprising:
providing a plurality of DNA segments for the directional cloning; incubating a lentiviral vector, the plurality of DNA segments, restriction enzymes, and DNA ligases in a single container at a room temperature for a period less than 30 minutes to obtain the lentiviral vector comprising a recombinant DNA molecule comprising the plurality of DNA segments in a desired direction; and mixing the lentiviral vector with a competent host cell.
2 . The method of claim 1 , wherein a positive rate of the directional cloning is greater than 80%.
3 . The method of claim 2 , wherein the number of the plurality of DNA segments is more than 2.
4 . The method of claim 1 , wherein comprises amplifying DNA segments by polymerase chain reaction (PCR) to obtain the plurality of DNA segments, respectively, and the plurality of DNA segment are a plurality of modified DNA segment.
5 . The method of claim 1 , wherein the restriction enzyme comprises a type II restriction enzyme.
6 . The method of claim 5 , wherein the restriction enzymes comprise at least one of BsaI, BbsI, BsmBI, Alw26I, AarI, BsmAI, BsmFI, BspMI, BtgZI, SfaNI, or LguI.
7 . The method of claim 1 , wherein the DNA ligases comprise at least one of T4 DNA ligase or E. coli DNA ligase.
8 . The method of claim 1 , wherein an individual DNA segment of the plurality of DNA segments comprising adaptors, and the recombinant DNA molecule does not comprise adaptors.
9 . The method of claim 1 , wherein the period is less than 15 minutes.
10 . The method of claim 1 , wherein the period is about 10 minutes.
11 . A reaction mixture for use in directional cloning, the reaction mixture comprising a plurality of DNA segments, a lentiviral vector, a plurality of amplified DNA segments for the directional cloning, restriction enzymes, and DNA ligases, wherein the number of the plurality of DNA segments is more than 2, and the directional cloning is performed at a room temperature for a period less than 30 min.
12 . The reaction mixture of claim 11 , wherein a positive rate of the directional cloning is greater than 80%.
13 . The reaction mixture of claim 12 , wherein the number of the plurality of DNA segments is more than 2.
14 . The reaction mixture of claim 11 , wherein comprises amplifying DNA segments by polymerase chain reaction (PCR) to obtain the plurality of DNA segments, respectively, and the plurality of DNA segment are a plurality of modified DNA segment.
15 . The reaction mixture of claim 11 , wherein the restriction enzyme comprises a type II restriction enzyme.
16 . The reaction mixture of claim 15 , wherein the restriction enzymes comprise at least one of BsaI, BbsI, BsmBI, Alw26I, AarI, BsmAI, BsmFI, BspMI, BtgZI, SfaNI, or LguI.
17 . The reaction mixture of claim 11 , wherein the DNA ligases comprise at least one of T4 DNA ligase or E. coli DNA ligase.
18 . The reaction mixture of claim 11 , wherein an individual DNA segment of the plurality of DNA segments comprising adaptors.Join the waitlist — get patent alerts
Track US2017218380A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.